These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8405514

  • 1. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
    [Abstract] [Full Text] [Related]

  • 2. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
    Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso S.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
    [Abstract] [Full Text] [Related]

  • 3. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
    [Abstract] [Full Text] [Related]

  • 4. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Popp-Snijders C, Schoemaker J.
    Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
    [Abstract] [Full Text] [Related]

  • 5. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC.
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [Abstract] [Full Text] [Related]

  • 6. Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials.
    Scheele F, van der Meer M, Lambalk CB, Schoute E, Schoemaker J, Hompes PG.
    Eur J Obstet Gynecol Reprod Biol; 1995 Oct; 62(2):221-4. PubMed ID: 8582500
    [Abstract] [Full Text] [Related]

  • 7. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M, Sjöblom P, Pousette A, Hillensjö T.
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [Abstract] [Full Text] [Related]

  • 8. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L, Von Hagen S, Larkins D, Ibrahim J, Santoro N.
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO, de Moura MD, Ferriani RA, Bailão LA, de Sá MF.
    Int J Fertil Menopausal Stud; 1993 Jun; 38(3):152-9. PubMed ID: 8348163
    [Abstract] [Full Text] [Related]

  • 11. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R.
    Cochrane Database Syst Rev; 2000 Jun; (4):CD000410. PubMed ID: 11034687
    [Abstract] [Full Text] [Related]

  • 12. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S, Schoemaker J.
    Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

  • 14. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 15. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
    Borm G, Mannaerts B.
    Hum Reprod; 2000 Jul; 15(7):1490-8. PubMed ID: 10875855
    [Abstract] [Full Text] [Related]

  • 16. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
    Sagle MA, Hamilton-Fairley D, Kiddy DS, Franks S.
    Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
    [Abstract] [Full Text] [Related]

  • 17. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.
    De Leo V, la Marca A, Ditto A, Morgante G, Cianci A.
    Fertil Steril; 1999 Aug; 72(2):282-5. PubMed ID: 10438996
    [Abstract] [Full Text] [Related]

  • 18. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y, Yamada H, Yoshida K, Manno T, Ubukata Y, Suzuki M, Yoshimura Y.
    Horm Res; 1990 Aug; 33 Suppl 2():43-8. PubMed ID: 2128881
    [Abstract] [Full Text] [Related]

  • 19. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U.
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.